Target baby food recalled due to possible elevated levels of lead
A company that makes baby food sold under a Target store brand is recalling more than 25,000 packages of a product because it may contain elevated levels of lead.
Miami-based Fruselva issued the recall in March for Target's Good & Gather Baby Pea, Zucchini, Kale & Thyme Vegetable Puree, sold in 4-ounce tubs, according to the U.S. Food and Drug Administration.
The packages include lot number 4167, with a best-by date of Dec. 7, and lot number 4169, with a best-by date of Dec. 9.
Consumers should not feed babies the products.
The recall is listed as Class II, which means the products are unlikely to cause serious harm, but still have the potential to result in temporary or reversible problems.
There is
no safe level of exposure to lead for children
, according to the U.S. Centers for Disease Control and Prevention. Exposure to the heavy metal can cause developmental and cognitive problems. Babies, children under 6 years old and pregnant women are at the highest risk when exposed to lead.
Earlier this month, Johnsonville recalled
over 22,600 pounds of cheddar bratwurst
in several states, including Minnesota and Wisconsin.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Dove Men+Care Encourages Canadian Dads to Celebrate ‘My Most Important Role' on LinkedIn
TORONTO--(BUSINESS WIRE)--To mark Father's Day, Dove Men+Care invites Canadian Dads and father figures to update their LinkedIn profiles with one of their most meaningful life roles: 'Dad.' Rolling out across Canada, the campaign encourages fathers to recognize and celebrate fatherhood as a full-time role and claim space for it on a platform traditionally reserved for professional milestones. As part of the campaign, Canadian Dads are encouraged to use LinkedIn's 'Add position' feature to reflect their role as a father and join a growing movement of men reshaping the traditional definition of masculinity, identity, and care. Making fatherhood LinkedIn-official, Dove Men+Care sparks a broader conversation that urges men to treat personal milestones with the same importance and visibility as professional ones. 'Too often, men proudly share promotions, but rarely the presence and care they bring at home,' said Divya Singh, General Manager, Personal Care, Unilever Canada. 'With this campaign, we are redefining success to include care and celebrate the powerful role fathers and father figures play beyond the workplace.' To kickstart the movement, Dove Men+Care partnered with Founder/CEO Ross Simmonds, Sports Commentator Donnovan Bennett, Celebrity Chef and TV host Dave Rocco, Innovation Strategist Shawn Kanungo. Each thought leader, known in Canada for their professional achievements, are sharing their personal fatherhood stories alongside custom visuals designed by Toronto-based illustrator Mateusz Napieralski. Canadians are encouraged to download and re-share these custom illustrations along with their own fatherhood update and journey. "When men see fatherhood as a vital part of who they are, it positively shapes their mental health and emotional well-being," said Dr. Andrew Howlett, a Toronto-based Child and Family Psychiatrist, and co-founder of the Fathers' Mental Health Network. "By valuing and supporting active fatherhood, we help dads feel recognized and empowered - building resilient families and healthier communities." As a long-time partner of Dove Men+Care, Dad Central, a national organization that provides research, programming, resources, and a community to support father involvement, is helping amplify the campaign through its extensive community network. The group is also contributing expert insight on the cultural importance of active fatherhood and its long-term impact on society. The campaign runs nationally in the lead-up to Father's Day, encouraging Dads across Canada to take part on LinkedIn. To learn more about Dove Men+Care, visit To find out more about Dad Central visit: About Dove Men+Care Dove Men+Care is the first range of products from Dove developed specially for men. Manufactured by Unilever, the line includes the #1 dermatologist recommended male bar and body wash brand. Launched in 2010, the Dove Men+Care portfolio includes bars, body washes, anti-perspirant/deodorants, and hair care. Dove Men+Care is available nationwide in food, drug, and mass outlet stores. About Unilever Unilever is one of the world's leading suppliers of Beauty & Wellbeing, Personal Care, Home Care, Foods and Ice Cream products, with sales in over 190 countries and products used by 3.4 billion people every day. We have 128,000 employees and generated sales of €60.8 billion in 2024. For more information about Unilever and our brands, please visit About Unilever in North America Unilever is one of the world's leading suppliers of Beauty & Wellbeing, Personal Care, Home Care, Foods and Ice Cream products, with sales in over 190 countries and products used by 3.4 billion people every day. We have 128,000 employees and generated sales of €60.8 billion in 2024. Our leading brands in North America include Dove, Hellmann's, Vaseline, Degree, Axe, TRESemmé, Knorr, Magnum, Ben & Jerry's, Nutrafol, Liquid I.V., Paula's Choice, and Dermalogica. For more information on Unilever U.S. and its brands visit: For more information on Unilever Canada and its brands visit: About Unilever in Canada Unilever is one of the world's leading suppliers of Beauty & Wellbeing, Personal Care, Home Care, Foods and Ice Cream products, with sales in over 190 countries and products used by 3.4 billion people every day. We have 128,000 employees and generated sales of €60.8 billion in 2024. Our leading brands in Canada include Dove, Vaseline, Degree, Axe, SheaMoisture, TRESemmé, Knorr, Hellmann's, Breyers, Magnum, Ben & Jerry's, Liquid I.V., and OLLY. For more information on Unilever Canada and visit: or About Dad Central Dad Central is a national non-profit organization dedicated to supporting and promoting responsible father involvement in Canada. Through evidence-based research, resources, and community programming, Dad Central helps fathers, families, and organizations recognize and strengthen the important role dads play in child development and family well-being. With over two decades of experience, Dad Central works to ensure every child has the opportunity to benefit from an involved and caring father.
Associated Press
2 hours ago
- Associated Press
Longeveron® to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
Published [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] MIAMI, June 09, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that Wa'el Hashad, CEO, will present at the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference, taking place June 16-17, 2025. Details for the Company's corporate presentation: Pre-recorded presentation available on-demand Monday, June 16, at 7:00 a.m. ET Longeveron presentation webcast link: Click Here The webcast for this conference presentation may be accessed at the ' Events and Presentations ' section of the Company's website. A replay of the webcast will be available on the Longeveron website for 90 days following the conference. About Longeveron Inc. Longeveron is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company's lead investigational product is laromestrocel (Lomecel-B™), an allogeneic mesenchymal stem cell (MSC) therapy product isolated from the bone marrow of young, healthy adult donors. Laromestrocel has multiple potential mechanisms of action encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas. Longeveron is currently pursuing three pipeline indications: hypoplastic left heart syndrome (HLHS), Alzheimer's disease, and Aging-related Frailty. Laromestrocel development programs have received five distinct and important FDA designations: for the HLHS program - Orphan Drug designation, Fast Track designation, and Rare Pediatric Disease designation; and, for the AD program - Regenerative Medicine Advanced Therapy (RMAT) designation and Fast Track designation. For more information, visit or follow Longeveron on LinkedIn , X , and Instagram . Investor and Media Contact: Derek Cole Investor Relations Advisory Solutions [email protected]
Yahoo
2 hours ago
- Yahoo
ReproTech LLC ("ReproTech") has made a significant growth investment in Matcher Technologies Ltd ("Matcher") to support its expansion across the fertility sector
DOVER, Del., June 9, 2025 /PRNewswire/ -- ReproTech, a leading provider of reproductive cryostorage and cryostorage technology solutions, is pleased to announce a significant investment in Matcher Technologies Ltd, a recognized innovator in the fertility industry known for its flagship electronic witnessing product, IMT Matcher. This strategic investment strengthens ReproTech's leadership in cryostorage by enhancing its existing traceability solutions. The integration of Matcher's expertise and technology with ReproTech's existing suite of cryostorage and safety focused products marks a major step towards the first comprehensive platform for patients and clinics to digitally document every step of the IVF process while providing the safest storage solutions on the market. "We are thrilled to partner with Matcher to continue our combined journey of providing the highest quality, safest and most compliant products for our clinic partners," said Brad Senstra, ReproTech CEO. "Their team, technology, mission and values align perfectly with our commitment to exceptional service, advanced technologies, and stringent compliance standards." Matcher Technologies Ltd, founded in 2005, has built a strong reputation for the capability and quality of its product, continual innovation, and excellent customer service. Following the investment, Matcher's operations will continue from its U.K. headquarters uninterrupted for end users and the existing distributor network. "ReproTech's reputation as a trusted storage solutions partner—with 35 years of experience—and their dedication to advancing traceability in fertility care make them an ideal partner," said George Heywood, CEO of Matcher Technologies Ltd. "Together, we can drive innovation and enhance our service offerings in both domestic and international markets." ReproTech was advised by Shoosmiths LLP, BDO LLP, and Armstrong Teasdale LLP. Matcher Technologies Ltd was supported by Clearwater International, Brabners LLP, and Claritas Tax. For more information, visit the Reprotech or IMT Matcher website or contact: Media Contact:Joy ZardeckiSVP Business Development & Administrationjzardecki@ About ReproTech ReproTech is a Delaware-based provider of cryostorage technology solutions, off-site storage and logistics services. The company partners with fertility clinics, hospital systems, donor banks, and andrology laboratories across North America to offer secure, state-of-the-art storage for sperm, oocytes, embryos, stem cells, oncofertility specific tissues, and other reproductive tissues - ensuring patients have future options for family formation. ReproTech distinguishes itself through exceptional service, advanced technologies, and stringent compliance standards. Learn more at About Matcher Technologies Ltd Matcher Technologies Ltd. is a UK based, global leader in fertility technology, renowned for developing IMT Matcher - the world's first electronic witnessing system - over 20 years ago. Over the past two decades, the company has played a pivotal role in shaping industry standards and educating the market. Built on insights from hundreds of fertility center customers worldwide, IMT Matcher has become the highest quality witnessing and traceability system of choice for clinics across the globe. With a deep commitment to innovation, Matcher has continuously invested in product development, driven by a highly skilled, multi-disciplinary, global team. The company's commitment to quality is underscored by longstanding relationships with global players and a trusted reputation for delivering excellent customer service in pursuit of protecting patients, fertility centers and donor banks from the risks of error in IVF. Learn more at View original content to download multimedia: SOURCE ReproTech, LLC Sign in to access your portfolio
